Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Carboxypeptidase G2

EU orphan designation number: EU/3/02/128   
Active ingredient: Carboxypeptidase G2
Indication: Adjunctive treatment in patients at risk of methotrexate toxicity
Sponsor: BTG Management Services Limited
5 Fleet Place, London EC4M 7RD, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
05/02/2003 Orphan designation EMEA/OD/049/02 (2003)471 of 03/02/2003
16/12/2004 Transfer of orphan designation EMEA/OD/049/02/T/01 (2004)4830 of 15/12/2004
26/03/2015 Change of name and/or address of sponsor